CD36 and atherosclerosis: This study was conducted to investigate the potential association of circulating CD36+ and BLTR1+ MMVs with femoral atherosclerosis on the one hand, and AA and EPA contents in atherosclerotic plaques, plasma, and granulocytes on the other.